Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
Back to Search Results

Connection

Search Results to Vivian Shi

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Shi, Vivian

Item TypeName
Concept Administration, Topical
Concept Administration, Cutaneous
Concept Drug Administration Routes
Concept United States Food and Drug Administration
Concept Drug Administration Schedule
Academic Article Bathing Additives for Atopic Dermatitis - A Systematic Review.
Academic Article Reactivation of Alopecia Areata After Dupilumab Therapy for Atopic Dermatitis.
Academic Article Natural Oils for Skin-Barrier Repair: Ancient Compounds Now Backed by Modern Science.
Academic Article Multiple labial melanotic macules occurring after topical application of calcineurin inhibitors.
Academic Article A Practical Approach to Recalcitrant Face and Neck Dermatitis in Atopic Dermatitis.
Academic Article Pearls in Mitigating Application Pain of Topical Nonsteroidal Agents.
Academic Article Topical probiotics: the unknowns behind their rising popularity.
Academic Article Bioactive: A new era of bioactive ingredients in topical formulations for inflammatory dermatoses.
Academic Article A comparison of international management guidelines for atopic dermatitis.
Academic Article 100% Complete response rate in patients with cutaneous metastatic melanoma treated with intralesional interleukin (IL)-2, imiquimod, and topical retinoid combination therapy: results of a case series.
Academic Article Current and emerging therapies for hand eczema.
Academic Article Reducing unpleasant side effects of topical 5-Fluorouracil treatment for actinic keratosis: a randomized controlled trial.
Academic Article Management Recommendations for Dupilumab Partial and Non-durable Responders in Atopic Dermatitis.
Academic Article Response to: "Special editorial: When prescribing Janus kinase inhibitors for dermatologic conditions, be mindful of the Food and Drug Administration's September 1, 2021, data safety communication".

Search Criteria
  • Organization and Administration